West Pharmaceutical Services
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other...
Latest News
12 days ago · zacks.com
West Pharmaceutical Services (WST) is a Great Momentum Stock: Should You Buy?Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum investors? Let's find out.
13 days ago · prnewswire.com
West to Participate in Upcoming Investor ConferenceEXTON, Pa., Nov. 4, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026, at 8:00 a.m. GMT in London, UK.
17 days ago · marketbeat.com
What West Pharmaceutical Services (WST) Said on Its Q3 Earnings CallWest Pharmaceutical Services NYSE: WST reported third-quarter results that exceeded its expectations, driven by continued demand for high-value product components, including those used in GLP-1 therapies and biologics. The company raised its full-year revenue and adjusted earnings outlook following the quarter.
18 days ago · seekingalpha.com
West Pharmaceutical Services, Inc. (WST) Q3 2026 Earnings Call TranscriptWest Pharmaceutical Services, Inc. (WST) Q3 2026 Earnings Call Transcript
19 days ago · zacks.com
West Pharma Q3 Earnings Rise on HVP Strength, 2026 Outlook RaisedWST reports strong Q3 earnings and revenue growth, fueled by high-value products and margin expansion, and raises its 2026 sales and earnings outlook.
19 days ago · zacks.com
Compared to Estimates, West Pharmaceutical (WST) Q3 Earnings: A Look at Key MetricsAlthough the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
19 days ago · zacks.com
West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top EstimatesWest Pharmaceutical Services (WST) came out with quarterly earnings of $2.66 per share, beating the Zacks Consensus Estimate of $2.18 per share. This compares to earnings of $1.96 per share a year ago.
19 days ago · prnewswire.com
West Reports Third-Quarter 2026 ResultsRaising Full-Year Net Sales and Adjusted-Diluted EPS guidance EXTON, Pa., Oct. 29, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the third quarter of 2026.
20 days ago · zacks.com
West Pharmaceutical (WST) Q3 Earnings Preview: What You Should Know Beyond the Headline EstimatesGet a deeper insight into the potential performance of West Pharmaceutical (WST) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
21 days ago · zacks.com
WST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?WST's Q3 earnings may benefit from strong HVP demand, biologics and GLP-1 growth, but West Vantage weakness and the SmartDose divestiture could weigh on sales.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove WST